Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Study Record Versions now shows a new latest revision (v3.7.0) and removes the previous revision (v3.6.6). This reflects a platform release update.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the record history and the prior 'Revision: v3.6.5' entry was removed, reflecting an update to the platform version displayed on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedNew revision entry v3.6.5 appears in the study's history, replacing the prior v3.6.4 entry. This update affects the record's version history rather than the study data or trial details.SummaryDifference0.1%

- Check74 days agoChange DetectedRecord History now includes a new revision entry updating the version from v3.6.3 to v3.6.4. This reflects a maintenance release noted in the study's version history.SummaryDifference0.1%

- Check96 days agoChange DetectedA new page revision entry (v3.6.3) was added and the previous revision (v3.6.2) removed, updating the study record's revision history. This reflects an administrative update to the page's metadata rather than changes to the study data or visible content.SummaryDifference0.1%

- Check103 days agoChange DetectedA new version entry labeled Revision: v3.6.2 was added to the study's version history, and the previous entry Revision: v3.6.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.